Alerts will be sent to your verified email
Verify Email
OLYOI
|
Olympic Oil Inds
|
EVOQ Remedies
|
Vivanza Biosciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.71 % | 22.13 % | 6.33 % |
|
5yr Avg Net Profit Margin
|
0.0 | 6.55 % | 1.43 % |
|
Price to Book
|
0.0 | 0.0 | 2.02 |
|
P/E
|
0.0 | 95.64 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 764.12 Days | 61.79 Days |
|
5yr Average Interest Coverage Ratio
|
-540.1 | 2684.0 | 1.78 |
|
5yr Avg ROCE
|
2.03 % | 29.72 % | 14.92 % |
|
5yr Avg Operating Profit Margin
|
0.0 | -8.09 % | 0.93 % |
|
5 yr average Debt to Equity
|
-4.99 | 0.24 | 0.98 |
|
5yr CAGR Net Profit
|
-45.41 % | n/a | n/a |
|
5yr Average Return on Assets
|
-0.62 % | 3.61 % | 1.37 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
24.13 % | 11.21 % | 20.02 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -62.32 % | -27.78 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Olympic Oil Inds
|
EVOQ Remedies
|
Vivanza Biosciences
|
|---|